Sponsored By
Farm Progress

Novozymes expands biologicals with EMD purchase

March 15, 2011

Novozymes is branching further into the U.S. biological market with the purchase of EMD/Merck Crop BioScience. David Fox, Novozymes marketing manager, explains why there's a growth in biologicals for the farm market. To view more videos, visit http://farmindustrynews.com/media

Subscribe to receive top agriculture news
Be informed daily with these free e-newsletters

You May Also Like